Cargando…
Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer
Aberrant DNA methylations have been reported to be significantly associated with lung squamous cell cancer (LUSC). The aim of this study was to investigate the DNA methylation-driven genes in LUSC by integrative bioinformatics analysis. In the present study, methylation-driven genes in LUSC were scr...
Autores principales: | Han, Pengkai, Liu, Qiping, Xiang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924172/ https://www.ncbi.nlm.nih.gov/pubmed/31897186 http://dx.doi.org/10.3892/ol.2019.11163 |
Ejemplares similares
-
Research progress on the therapeutic effect and mechanism of metformin for lung cancer
por: Han, Pengkai, et al.
Publicado: (2022) -
Identification of Prognostic Genes and Immune Landscape Signatures Based on Tumor Microenvironment in Lung Adenocarcinoma
por: Han, Pengkai, et al.
Publicado: (2022) -
Methylation-driven genes PMPCAP1, SOWAHC and ZNF454 as potential prognostic biomarkers in lung squamous cell carcinoma
por: Zhu, Qingqing, et al.
Publicado: (2020) -
Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018) -
Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma
por: Yang, Xuejie, et al.
Publicado: (2022)